Natixis Advisors, L.P. Globus Medical Inc Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Globus Medical Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 257,743 shares of GMED stock, worth $21.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
257,743
Previous 259,512
0.68%
Holding current value
$21.4 Million
Previous $17.8 Million
3.74%
% of portfolio
0.04%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding GMED
# of Institutions
479Shares Held
104MCall Options Held
183KPut Options Held
57.3K-
Vanguard Group Inc Valley Forge, PA10.6MShares$883 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$859 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07MShares$582 Million0.27% of portfolio
-
State Street Corp Boston, MA3.57MShares$297 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$216 Million0.02% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.4B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...